Skip to main content

Advertisement

Log in

Genistein modulates the anti-tumor activity of cisplatin in MCF-7 breast and HT-29 colon cancer cells

  • Molecular Toxicology
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The function of genistein (GEN) on tumor prevention and tumor promotion is discussed controversially. A possible interference of GEN with chemotherapy has been only rarely addressed so far. In this study, effects of GEN on the anti-tumor activity of cisplatin (CIS) were investigated in the presence and absence of estradiol (10−10 M) in MCF-7 breast and HT-29 colon cancer cells. Cells were treated with graded concentrations of GEN (10−4–10−6 M), E2, CIS and combinations. Cell growth, proliferation and apoptosis were determined as well as the expression level of PCNA, Ki67 and BCL-2 family members. CIS and GEN 10−4 M inhibited cell growth and induced apoptosis in MCF-7 and HT-29 cells in the presence and absence of E2. Co-treatment with CIS and 10−4M GEN resulted in additive effects. In concentrations of 10−5 and 10−6 M, GEN stimulated cell growth in MCF-7 cells. It promoted proliferation, inhibited apoptosis and counteracted the anti-tumor activity of CIS in MCF-7 and HT-29 cells. Particularly the ability of CIS to induce apoptosis was antagonized. In ER alpha-positive MCF-7 cells, but not in ER alpha-negative HT-29 cells, E2 was able to neutralize the anti-CIS effects of GEN. Our data provide evidence that GEN in the absence of E2, a situation which occurs in postmenopausal women, directly affects the anti-tumor activity of cytostatic drugs like CIS. The exact molecular mechanism has to be investigated in future studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

CIS:

Cisplatin

GEN:

Genistein

ER:

Estrogen receptor

E2 :

Estradiol

PMSF:

Phenylmethanesulfonylfluoride

References

  • Adjakly M, Ngollo M, Boiteux JP, Bignon YJ, Guy L, Bernard-Gallon D (2013) Genistein and daidzein: different molecular effects on prostate cancer. Anticancer Res 33(1):39–44

    CAS  PubMed  Google Scholar 

  • Akhdar H, Legendre C, Aninat C, More F (2012) Anticancer drug metabolism: chemotherapy resistance and new therapeutic approaches. In: Paxton J (ed) Topics on drug metabolism. InTech Europe, Rijeka. ISBN:978-953-51-0099-7. doi:10.5772/30015. Available from: http://www.intechopen.com/books/topics-on-drug-metabolism/anticancer-drug-metabolism-chemotherapyresistance-and-new-therapeutic-approaches

  • Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itho N, Shibuya M, Fukami Y (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. JBC 262(12):5592–5595

    CAS  Google Scholar 

  • Bolca S, Urpi-Sarda M, Blondeel P et al (2010) Disposition of soy isoflavones in normal human breast tissue. Am J Clin Nutr 91(4):976–984. doi:10.3945/ajcn.2009.28854

    Article  CAS  PubMed  Google Scholar 

  • Chang HC, Churchwell MI, Delclos KB, Newbold RR, Doerge DR (2000) Mass spectrometric determination of Genistein tissue distribution in diet-exposed Sprague-Dawley rats. J Nutr 130(8):1963–1970

    CAS  PubMed  Google Scholar 

  • Chen WF, Wong MS (2004) Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells. J Clin Endocrinol Metab 89(5):2351–2359

    Article  CAS  PubMed  Google Scholar 

  • Chon HS, Marchion DC, Xiong Y et al (2012) The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin. Gynecol Oncol 124(1):119–124. doi:10.1016/j.ygyno.2011.09.020

    Article  CAS  PubMed  Google Scholar 

  • Craig WJ (2010) Nutrition concerns and health effects of vegetarian diets. Nutr Clin Pract 25(6):613–620. doi:10.1177/0884533610385707

    Article  PubMed  Google Scholar 

  • Degen GH, Janning P, Diel P, Michna H, Bolt HM (2002) Transplacental transfer of the phytoestrogen daidzein in DA/Han rats. Arch Toxicol 76(1):23–29

    Article  CAS  PubMed  Google Scholar 

  • Dhandayuthapani S, Marimuthu P, Hormann V, Kumi-Diaka J, Rathinavelu A (2013) Induction of apoptosis in HeLa cells via caspase activation by resveratrol and genistein. J Med Food 16(2):139–146. doi:10.1089/jmf2012.0141

    Article  CAS  PubMed  Google Scholar 

  • Diel P, Smolnikar K, Michna H (1999) The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells. Breast Cancer Res Treat 58(2):87–97

    Article  CAS  PubMed  Google Scholar 

  • Drosdzol A, Skrzypulec V, Nowosielski K, Piela B, Rozmus-Warcholinska W, Walaszek A (2004) Phytoestrogens: an alternative to hormonal replacement therapy. Wiad Lek 57(Suppl 1):74–77

    PubMed  Google Scholar 

  • Hayashi N, Niikura N, Yamauchi H, Nakamura S, Ueno NT (2013) Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer. Breast Cancer Res Treat 137(2):523–531. doi:10.1007/s10549-012-2336-6

    Article  CAS  PubMed  Google Scholar 

  • Helferich WG, Andrade JE, Hoagland MS (2008) Phytoestrogens and breast cancer: a complex story. Inflammopharmacology 16(5):219–226. doi:10.1007/s10787-008-8020-0

    Article  CAS  PubMed  Google Scholar 

  • Hsieh TF, Chen CC, Yu AL et al (2013) Androgen receptor decreases the cytotoxic effects of chemotherapeutic drugs in upper urinary tract urothelial carcinoma cells. Oncol Lett 5(4):1325–1330. doi:10.3892/ol.2013.1140

    CAS  PubMed Central  PubMed  Google Scholar 

  • Hwang KA, Kang NH, Yi BR, Lee HR, Park MA, Choi KC (2013) Genistein, a soy phytoestrogen, prevents the growth of BG-1 ovarian cancer cells induced by 17beta-estradiol or bisphenol A via the inhibition of cell cycle progression. Int J Oncol 42(2):733–740. doi:10.3892/ijo.2012.1719

    CAS  PubMed  Google Scholar 

  • Ju YH, Allred KF, Allred CD, Helferich WG (2006) Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations. Carcinogenesis 27(6):1292–1299

    Article  CAS  PubMed  Google Scholar 

  • Karaca B, Atmaca H, Uzunoglu S, Karabulut B, Sanli UA, Uslu R (2009) Enhancement of taxane-induced cytotoxicity and apoptosis by gossypol in human breast cancer cell line MCF-7. J BUON 14(3):479–485

    CAS  PubMed  Google Scholar 

  • Köberle B, Tomicic MT, Usanova S, Kaina B (2010) Cisplatin resistance: Preclinical findings and clinical implications. Biochim Biophys Acta 1806(2):172–182. doi:10.1016/j.bbcan.2010.07.004

    PubMed  Google Scholar 

  • Korbakis D, Scorilas A (2012) Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol. Tumour Biol 33(3):865–875. doi:10.1007/s13277-011-0313-z

    Article  CAS  PubMed  Google Scholar 

  • Lagari VS, Levis S (2012) Phytoestrogens for menopausal bone loss and climacteric symptoms. J Steroid Biochem Mol Biol. doi:10.1016/j.jsbmb.2012.12.002

  • Li H, Tu Z, An L, Qian Z, Achilefu S, Gu Y (2012) Inhibitory effects of ERbeta on proliferation, invasion, and tumor formation of MCF-7 breast cancer cells–prognostication for the use of ERbeta-selective therapy. Pharmaceutical biology 50(7):839–849. doi:10.3109/13880209.2011.637506

    Article  CAS  PubMed  Google Scholar 

  • Li Y, Meeran SM, Patel SN, Chen H, Hardy TM, Tollefsbol TO (2013) Epigenetic reactivation of estrogen receptor-alpha (ERalpha) by genistein enhances hormonal therapy sensitivity in ERalpha-negative breast cancer. Mol Cancer 12(1):9. doi:10.1186/1476-4598-12-9

    Article  PubMed Central  PubMed  Google Scholar 

  • Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA (2000) Daidzein and genistein contents of vegetables. British J Nutr 84(5):717–725

    CAS  Google Scholar 

  • Markert A, Thierry V, Kleber M, Behrens M, Engelhardt M (2009) Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment. Int J Cancer 124(3):722–728. doi:10.1002/ijc.23991

    Article  CAS  PubMed  Google Scholar 

  • Maubach J, Bracke ME, Heyerick A, Depypere HT, Serreyn RF, Mareel MM, De Keukeleire D (2003) Quantitation of soy-derived phytoestrogens in human breast tissue and biological fluids by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 784(1):137–144

    Article  CAS  PubMed  Google Scholar 

  • Maubach J, Depypere HT, Goeman J, Van der Eycken J, Heyerick A, Bracke ME, Blondeel P, De Keukeleire D (2004) Distribution of soy-derived phytoestrogens in human breast tissue and biological fluids. Obstet Gynecol 103(5):892–898

    Article  CAS  PubMed  Google Scholar 

  • Miltyk W, Craciunescu CN, Fischer L, Jeffcoat RA, Koch MA, Lopaczynski W, Mahoney C, Jeffcoat RA, Crowell J, Paglieri J, Zeisel SH (2003) Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer. Am J Clin Nutr 77(4):875–882

    CAS  PubMed  Google Scholar 

  • Mohammad Javad Mokhtari AA, Hashemi M, Javadi G, Mahdian R, Mehrabi MR, Farhangi A, Mohammadi H (2012) Cisplatin Induces Down Regulation of BCL2 in T47D Breast Cancer Cell Line. Adv Stud Biol 4(1):19–25

    Google Scholar 

  • Murkies AL, Wilcox G, Davis SR (1998) Clinical review 92: phytoestrogens. J Clin Endocrinol Metab 83(2):297–303. doi:10.1210/jc.83.2.297

    CAS  PubMed  Google Scholar 

  • Perillo B, Sasso A, Abbondanza C, Palumbo G (2000) 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20(8):2890–2901

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Qi W, Weber CR, Wasland K, Savkovic SD (2011) Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer 11:219. doi:10.1186/1471-2407-11-219

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rannikko A, Petas A, Rannikko S, Adlercreutz H (2006) Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestrogen supplementation. Prostate 66(1):82–87. doi:10.1002/pros.20315

    Article  CAS  PubMed  Google Scholar 

  • Sarkar FH, Li Y (2006) Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res 66(7):3347–3350. doi:10.1158/0008-5472.can-05-4526

    Article  CAS  PubMed  Google Scholar 

  • Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE (1997) Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet. 5;350(9070):23-27

    Google Scholar 

  • Shin JI, Shim JH, Kim KH et al (2008) Sensitization of the apoptotic effect of gamma-irradiation in genistein-pretreated CaSki cervical cancer cells. J Microbiol Biotechnol 18(3):523–531

    CAS  PubMed  Google Scholar 

  • Ullah MF, Ahmad A, Zubair H et al (2011) Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen species. Mol Nutr Food Res 55(4):553–559. doi:10.1002/mnfr.201000329

    Article  CAS  PubMed  Google Scholar 

  • van Duursen MB, Nijmeijer SM, de Morree ES, de Jong PC, van den Berg M (2011) Genistein induces breast cancer-associated aromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model. Toxicology 289(2–3):67–73. doi:10.1016/j.tox.2011.07.005

    Article  PubMed  Google Scholar 

  • Wang TT, Sathyamoorthy N, Phang JM (1996) Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17(2):271–275

    Article  PubMed  Google Scholar 

  • Wang Y, Wang H, Zhang W et al (2013) Genistein Sensitizes Bladder Cancer Cells to HCPT Treatment In Vitro and In Vivo via ATM/NF-kappaB/IKK Pathway-Induced Apoptosis. PLoS ONE 8(1):e50175. doi:10.1371/journal.pone.0050175

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Xia J, Duan Q, Ahmad A et al (2012) Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Curr Drug Targets 13(14):1750–1756

    Article  CAS  PubMed  Google Scholar 

  • Yan GR, Zou FY, Dang BL et al (2012) Genistein-induced mitotic arrest of gastric cancer cells by downregulating KIF20A, a proteomics study. Proteomics 12(14):2391–2399. doi:10.1002/pmic.201100652

    Article  CAS  PubMed  Google Scholar 

  • Yuan B, Wang L, Jin Y et al (2012) Role of metabolism in the effects of genistein and its phase II conjugates on the growth of human breast cell lines. AAPS J 14(2):329–344. doi:10.1208/s12248-012-9338-5

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We appreciate DAAD scholarship’s financial support. We thank Raoul Kempkes for his help on the flow cytometry assay and Prof. Pablo Steinberg for supporting with HCEC cells. We also thank Carmen Weigt for reading the manuscript. This study was supported by a grant support from Sino-German Center (No. GZ731) and by International Science and Technology Cooperation Projects (No. 2010DFA31780).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ming-Yong Xie or Patrick Diel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, XJ., Xie, MY., Kluxen, F.M. et al. Genistein modulates the anti-tumor activity of cisplatin in MCF-7 breast and HT-29 colon cancer cells. Arch Toxicol 88, 625–635 (2014). https://doi.org/10.1007/s00204-013-1184-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-013-1184-4

Keywords

Navigation